Regulus Therapeutics Ownership 2024 | Who Owns Regulus Therapeutics Now?
Institutional Ownership
189.38%
Insider Ownership
1.69%
Retail Ownership
-91.07%
Institutional Holders
62.00
Regulus Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 44.71% | 0.05% | 12,852,654 | - | - | 22,941,988,000 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 21.74% | 0.15% | 6,250,000 | - | - | 11,156,250 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 17.39% | 0.82% | 5,000,000 | - | - | 8,925,000 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 14.83% | 1.20% | 4,263,701 | 4,263,701 | 100.00% | 7,610,706 | Jun 30, 2024 |
| VANGUARD GROUP INC | 14.09% | 0.00% | 4,050,863 | 3,310,648 | 447.25% | 7,230,791 | Jun 30, 2024 |
| BLACKROCK INC. | 13.81% | 0.00% | 3,968,857 | 3,900,826 | 5733.89% | 7,084,410 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 11.35% | 0.17% | 3,262,564 | -4,002 | -0.12% | 5,823,677 | Jun 30, 2024 |
| FMR LLC | 7.04% | 0.00% | 2,022,600 | -900,000 | -30.79% | 3,610,341 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.96% | 0.01% | 2,000,000 | -1,679,854 | -45.65% | 3,570,000 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 5.13% | 0.60% | 1,475,000 | 1,304,692 | 766.08% | 2,632,875 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.64% | 0.00% | 1,333,509 | 1,172,919 | 730.38% | 2,380,397 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 4.23% | 0.00% | 1,215,581 | -659,645 | -35.18% | 2,169,812 | Jun 30, 2024 |
| STATE STREET CORP | 3.37% | 0.00% | 967,502 | 925,783 | 2219.09% | 1,726,991,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 3.30% | 0.02% | 947,685 | 947,685 | 100.00% | 1,691,618 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 3.26% | 0.01% | 937,500 | - | - | 1,673,438 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 3.11% | 0.38% | 895,200 | -175,348 | -16.38% | 1,597,932 | Jun 30, 2024 |
| CVI HOLDINGS, LLC | 1.40% | 0.62% | 401,012 | -1,005,238 | -71.48% | 715,806 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 1.26% | 0.00% | 361,386 | -6,760 | -1.84% | 645,074 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.15% | 0.00% | 329,639 | 329,639 | 100.00% | 588,000 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.87% | 0.00% | 249,940 | -375,060 | -60.01% | 446,143 | Jun 30, 2024 |
Regulus Therapeutics's largest institutional shareholder is FEDERATED HERMES, INC., holding 44.71% of the company's total share outstanding, currently valued at $22.94B. The top 10 institutional shareholders own together 157.05% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | 14.83% | 1.20% | 4,263,701 | 4,263,701 | 100.00% | 7,610,706 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 17.39% | 0.82% | 5,000,000 | - | - | 8,925,000 | Jun 30, 2024 |
| CVI HOLDINGS, LLC | 1.40% | 0.62% | 401,012 | -1,005,238 | -71.48% | 715,806 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 5.13% | 0.60% | 1,475,000 | 1,304,692 | 766.08% | 2,632,875 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 3.11% | 0.38% | 895,200 | -175,348 | -16.38% | 1,597,932 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 11.35% | 0.17% | 3,262,564 | -4,002 | -0.12% | 5,823,677 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 21.74% | 0.15% | 6,250,000 | - | - | 11,156,250 | Jun 30, 2024 |
| SARISSA CAPITAL MANAGEMENT LP | 0.64% | 0.06% | 185,183 | - | - | 330,552 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 44.71% | 0.05% | 12,852,654 | - | - | 22,941,988,000 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.69% | 0.05% | 197,049 | -427,951 | -68.47% | 351,732 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.21% | 0.02% | 59,004 | 59,004 | 100.00% | 105,322 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 3.30% | 0.02% | 947,685 | 947,685 | 100.00% | 1,691,618 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 3.26% | 0.01% | 937,500 | - | - | 1,673,438 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.96% | 0.01% | 2,000,000 | -1,679,854 | -45.65% | 3,570,000 | Jun 30, 2024 |
| TYCHE WEALTH PARTNERS LLC | 0.04% | 0.00% | 10,395 | 10,395 | 100.00% | 18,555 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.15% | 0.00% | 329,639 | 329,639 | 100.00% | 588,000 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.87% | 0.00% | 249,940 | -375,060 | -60.01% | 446,143 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.05% | 0.00% | 14,100 | -118,370 | -89.36% | 25,169 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 4.23% | 0.00% | 1,215,581 | -659,645 | -35.18% | 2,169,812 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.13% | 0.00% | 38,451 | 38,451 | 100.00% | 68,635 | Jun 30, 2024 |
The largest Regulus Therapeutics shareholder by % of total assets is OCTAGON CAPITAL ADVISORS LP. The company owns 4.26M shares of Regulus Therapeutics (RGLS), representing 1.20% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | 14.83% | 1.20% | 4,263,701 | 4,263,701 | 100.00% | 7,610,706 | Jun 30, 2024 |
| BLACKROCK INC. | 13.81% | 0.00% | 3,968,857 | 3,900,826 | 5733.89% | 7,084,410 | Jun 30, 2024 |
| VANGUARD GROUP INC | 14.09% | 0.00% | 4,050,863 | 3,310,648 | 447.25% | 7,230,791 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 5.13% | 0.60% | 1,475,000 | 1,304,692 | 766.08% | 2,632,875 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.64% | 0.00% | 1,333,509 | 1,172,919 | 730.38% | 2,380,397 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 3.30% | 0.02% | 947,685 | 947,685 | 100.00% | 1,691,618 | Jun 30, 2024 |
| STATE STREET CORP | 3.37% | 0.00% | 967,502 | 925,783 | 2219.09% | 1,726,991,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.15% | 0.00% | 329,639 | 329,639 | 100.00% | 588,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.69% | 0.00% | 197,193 | 197,193 | 100.00% | 351,990 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.62% | 0.00% | 178,879 | 178,879 | 100.00% | 319,299 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.60% | 0.00% | 172,750 | 154,772 | 860.90% | 308,359,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.30% | - | 85,602 | 85,602 | 100.00% | 152,800 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.27% | 0.00% | 76,472 | 76,472 | 100.00% | 136,495 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.21% | 0.00% | 60,000 | 60,000 | 100.00% | 107,100 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.21% | 0.02% | 59,004 | 59,004 | 100.00% | 105,322 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.17% | 0.00% | 49,400 | 49,400 | 100.00% | 88,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.41% | 0.00% | 118,100 | 42,600 | 56.42% | 210,809 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.13% | 0.00% | 38,451 | 38,451 | 100.00% | 68,635 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.12% | 0.00% | 35,299 | 35,299 | 100.00% | 63,009 | Jun 30, 2024 |
| MORGAN STANLEY | 0.22% | - | 62,970 | 35,151 | 126.36% | 112,401 | Jun 30, 2024 |
As of Jun 30 2024, Regulus Therapeutics's largest institutional buyer is OCTAGON CAPITAL ADVISORS LP. The company purchased 4.26M stocks of RGLS, valued at $7.61M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.96% | 0.01% | 2,000,000 | -1,679,854 | -45.65% | 3,570,000 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -1,562,500 | -100.00% | - | Jun 30, 2024 |
| CVI HOLDINGS, LLC | 1.40% | 0.62% | 401,012 | -1,005,238 | -71.48% | 715,806 | Jun 30, 2024 |
| FMR LLC | 7.04% | 0.00% | 2,022,600 | -900,000 | -30.79% | 3,610,341 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 4.23% | 0.00% | 1,215,581 | -659,645 | -35.18% | 2,169,812 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -536,400 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.69% | 0.05% | 197,049 | -427,951 | -68.47% | 351,732 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -402,504 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.87% | 0.00% | 249,940 | -375,060 | -60.01% | 446,143 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 3.11% | 0.38% | 895,200 | -175,348 | -16.38% | 1,597,932 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.05% | 0.00% | 14,100 | -118,370 | -89.36% | 25,169 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.48% | - | 138,465 | -88,954 | -39.11% | 247,160 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 3,622 | -71,828 | -95.20% | 6,000 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.16% | - | 46,980 | -66,500 | -58.60% | 83,859 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -62,797 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -24,253 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -18,500 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -8,607 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 1.26% | 0.00% | 361,386 | -6,760 | -1.84% | 645,074 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 11.35% | 0.17% | 3,262,564 | -4,002 | -0.12% | 5,823,677 | Jun 30, 2024 |
As of Jun 30 2024, Regulus Therapeutics's biggest institutional seller is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company sold -1.68M shares of RGLS, valued at $3.57M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | 14.83% | 1.20% | 4,263,701 | 4,263,701 | 100.00% | 7,610,706 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 3.30% | 0.02% | 947,685 | 947,685 | 100.00% | 1,691,618 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.15% | 0.00% | 329,639 | 329,639 | 100.00% | 588,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.69% | 0.00% | 197,193 | 197,193 | 100.00% | 351,990 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.62% | 0.00% | 178,879 | 178,879 | 100.00% | 319,299 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.30% | - | 85,602 | 85,602 | 100.00% | 152,800 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.27% | 0.00% | 76,472 | 76,472 | 100.00% | 136,495 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.21% | 0.00% | 60,000 | 60,000 | 100.00% | 107,100 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.21% | 0.02% | 59,004 | 59,004 | 100.00% | 105,322 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.17% | 0.00% | 49,400 | 49,400 | 100.00% | 88,000 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.13% | 0.00% | 38,451 | 38,451 | 100.00% | 68,635 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.12% | 0.00% | 35,299 | 35,299 | 100.00% | 63,009 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.12% | 0.00% | 33,974 | 33,974 | 100.00% | 60,983 | Jun 30, 2024 |
| INVESCO LTD. | 0.10% | - | 29,061 | 29,061 | 100.00% | 51,874 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.09% | - | 26,880 | 26,880 | 100.00% | 47,981 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.08% | - | 23,074 | 23,074 | 100.00% | 41,187 | Jun 30, 2024 |
| BARCLAYS PLC | 0.08% | - | 21,928 | 21,928 | 100.00% | 40,000 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.06% | 0.00% | 16,779 | 16,779 | 100.00% | 29,951 | Jun 30, 2024 |
| TYCHE WEALTH PARTNERS LLC | 0.04% | 0.00% | 10,395 | 10,395 | 100.00% | 18,555 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.02% | 0.00% | 6,187 | 6,187 | 100.00% | 11,044 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.02% | - | 5,956 | 5,956 | 100.00% | 10,632 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.02% | - | 5,948 | 5,948 | 100.00% | 11,000 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.02% | - | 4,576 | 4,576 | 100.00% | 8,168 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.01% | - | 2,185 | 2,185 | 100.00% | 4,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 800 | 800 | 100.00% | 1,428 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 10 | 10 | 100.00% | 18 | Jun 30, 2024 |
Regulus Therapeutics's largest new institutional shareholder by number of shares is OCTAGON CAPITAL ADVISORS LP, purchased 4.26M shares, valued at $7.61M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -1,562,500 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -536,400 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -402,504 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -62,797 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -24,253 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -18,500 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -8,607 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -3,212 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -865 | -100.00% | - | Jun 30, 2024 |
Regulus Therapeutics's largest sold out institutional shareholder by shares sold is SOLEUS CAPITAL MANAGEMENT, L.P., sold -1.56M shares, valued at -, as of undefined.
Regulus Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY SELECT PORTFOLIOS | 0.05% | 2,922,600 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.01% | 245,278 | 59,660 | 32.14% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 712,305 | 54,646 | 8.31% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 740,215 | 332,062 | 81.36% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 114,616 | -628 | -0.54% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 9,113 | - | - | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 184,600 | - | - | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 16,094 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 15,524 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 10,610 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 9,460 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,203 | - | - | Mar 31, 2024 |
Regulus Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY SELECT PORTFOLIOS", owning 2.92M shares, compromising 0.05% of its total assets.
Regulus Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 62 | 31.91% |
| 31 Mar, 24 | 47 | 88.00% |
| 31 Dec, 23 | 25 | 4.17% |
| 30 Sep, 23 | 24 | 4.35% |
| 30 Jun, 23 | 23 | - |
| 31 Mar, 23 | 23 | -4.17% |
| 31 Dec, 22 | 24 | 20.00% |
| 30 Sep, 22 | 20 | -16.67% |
| 30 Jun, 22 | 24 | - |
As of 30 Jun 24, 62 institutions are holding Regulus Therapeutics's shares, representing an increase of 31.91% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 54,440,317 | 19.33% |
| 31 Mar, 24 | 45,620,979 | 398.54% |
| 31 Dec, 23 | 9,150,867 | 2.37% |
| 30 Sep, 23 | 8,938,928 | 8.86% |
| 30 Jun, 23 | 8,211,251 | 24.77% |
| 31 Mar, 23 | 6,581,165 | -1.09% |
| 31 Dec, 22 | 6,653,406 | 0.27% |
| 30 Sep, 22 | 6,635,525 | 44.20% |
| 30 Jun, 22 | 4,601,673 | - |
Regulus Therapeutics (RGLS) has 54.44M shares outstanding as of 30 Jun 24, up 19.33% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 189.38% | 0.75% |
| 31 Mar, 24 | 158.70% | 7.75% |
| 31 Dec, 23 | 45.25% | 2.18% |
| 30 Sep, 23 | 45.54% | 2.46% |
| 30 Jun, 23 | 42.99% | 2.82% |
| 31 Mar, 23 | 39.07% | 2.06% |
| 31 Dec, 22 | 43.60% | 2.22% |
| 30 Sep, 22 | 44.33% | 4.47% |
| 30 Jun, 22 | 31.49% | - |
As of 30 Jun 24, Regulus Therapeutics is held by 189.38% institutional shareholders, representing a 0.75% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 40 | 11.11% |
| 31 Mar, 24 | 36 | 260.00% |
| 31 Dec, 23 | 10 | 11.11% |
| 30 Sep, 23 | 9 | -18.18% |
| 30 Jun, 23 | 11 | 57.14% |
| 31 Mar, 23 | 7 | -22.22% |
| 31 Dec, 22 | 9 | 12.50% |
| 30 Sep, 22 | 8 | -66.67% |
| 30 Jun, 22 | 24 | - |
40 institutional shareholders have increased their position in RGLS stock as of 30 Jun 24 compared to 36 in the previous quarter (a 11.11% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | 250.00% |
| 31 Mar, 24 | 4 | - |
| 31 Dec, 23 | 4 | -20.00% |
| 30 Sep, 23 | 5 | 400.00% |
| 30 Jun, 23 | 1 | -80.00% |
| 31 Mar, 23 | 5 | 25.00% |
| 31 Dec, 22 | 4 | 33.33% |
| 30 Sep, 22 | 3 | - |
| 30 Jun, 22 | - | - |
14 institutional shareholders have reduced their position in RGLS stock as of 30 Jun 24 compared to 4 in the previous quarter (a 250.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 62 | 31.91% | 54,440,317 | 19.33% | 189.38% | 0.75% | 40 | 11.11% | 14 | 250.00% |
| 31 Mar, 24 | 47 | 88.00% | 45,620,979 | 398.54% | 158.70% | 7.75% | 36 | 260.00% | 4 | - |
| 31 Dec, 23 | 25 | 4.17% | 9,150,867 | 2.37% | 45.25% | 2.18% | 10 | 11.11% | 4 | -20.00% |
| 30 Sep, 23 | 24 | 4.35% | 8,938,928 | 8.86% | 45.54% | 2.46% | 9 | -18.18% | 5 | 400.00% |
| 30 Jun, 23 | 23 | - | 8,211,251 | 24.77% | 42.99% | 2.82% | 11 | 57.14% | 1 | -80.00% |
| 31 Mar, 23 | 23 | -4.17% | 6,581,165 | -1.09% | 39.07% | 2.06% | 7 | -22.22% | 5 | 25.00% |
| 31 Dec, 22 | 24 | 20.00% | 6,653,406 | 0.27% | 43.60% | 2.22% | 9 | 12.50% | 4 | 33.33% |
| 30 Sep, 22 | 20 | -16.67% | 6,635,525 | 44.20% | 44.33% | 4.47% | 8 | -66.67% | 3 | - |
| 30 Jun, 22 | 24 | - | 4,601,673 | - | 31.49% | - | 24 | - | - | - |
Regulus Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of RGLS was made by Collier Kathryn J on Jul 29 2024, buying 4,000 shares at $1.82 per share (worth $7.28K).
Regulus Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 20 | - | - |
| Q1 2024 | 8 | 3 | 266.67% |
| Q3 2023 | 12 | - | - |
| Q2 2023 | 10 | - | - |
| Q1 2023 | 4 | - | - |
| Q2 2022 | 20 | - | - |
| Q1 2022 | 7 | - | - |
| Q4 2021 | 1 | - | - |
| Q2 2021 | 11 | 2 | 550.00% |
| Q1 2021 | 5 | 3 | 166.67% |
| Q4 2020 | 35 | 2 | 1750.00% |
| Q3 2020 | - | 2 | - |
| Q2 2020 | 8 | 9 | 88.89% |
| Q1 2020 | 6 | 6 | 100.00% |
| Q4 2019 | 45 | 4 | 1125.00% |
| Q3 2019 | 1 | 5 | 20.00% |
| Q2 2019 | 62 | 6 | 1033.33% |
| Q1 2019 | 8 | 1 | 800.00% |
| Q4 2018 | 12 | 36 | 33.33% |
| Q2 2018 | 19 | - | - |
20 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Regulus Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 3 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 3 | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | 2 | - |
| Q1 2021 | - | 3 | - |
| Q4 2020 | 30 | 2 | 1500.00% |
| Q3 2020 | - | 2 | - |
| Q2 2020 | - | 2 | - |
| Q1 2020 | - | 4 | - |
| Q4 2019 | 26 | 4 | 650.00% |
| Q3 2019 | - | 5 | - |
| Q2 2019 | 47 | 6 | 783.33% |
| Q1 2019 | - | - | - |
| Q4 2018 | 6 | - | - |
| Q2 2018 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Regulus Therapeutics's stocks.
RGLS Ownership FAQ
Who Owns Regulus Therapeutics?
Regulus Therapeutics is owned by institutional shareholders (189.38%), insiders (1.69%), and public (-91.07%). The largest institutional shareholder of Regulus Therapeutics is FEDERATED HERMES, INC. (44.71% of total shares) and the top mutual fund owner is FIDELITY SELECT PORTFOLIOS (0.05% of total shares).
Who are the major institutional shareholders of Regulus Therapeutics?
Regulus Therapeutics's major institutional shareholders are FEDERATED HERMES, INC., RA CAPITAL MANAGEMENT, L.P., VIVO CAPITAL, LLC, OCTAGON CAPITAL ADVISORS LP, and VANGUARD GROUP INC. The top five shareholders own together 112.77% of the company's share outstanding.
How many Regulus Therapeutics shareholders are there?
As of Jun 2024, there are 62 institutional shareholders of Regulus Therapeutics.
What percentage of Regulus Therapeutics is owned by FEDERATED HERMES, INC?
FEDERATED HERMES, INC owns 12.85M shares of Regulus Therapeutics, representing 44.71% of the company's total shares outstanding, valued at $22.94B (as of Jun 2024).
What percentage of Regulus Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
As of Jun 2024, RA CAPITAL MANAGEMENT, L.P holds 6.25M shares of Regulus Therapeutics (RGLS), compromising 21.74% of the company, valued at $11.16M.
What percentage of Regulus Therapeutics is owned by VIVO CAPITAL, LLC?
VIVO CAPITAL, LLC is the third largest holder of Regulus Therapeutics. The company owns 5M of the company's shares outstanding (worth $8.92M).